Degree of Labeling Impacts AOCs for Single-Cell Multi-Omics
If you’ve ever tried single-cell RNA sequencing (scRNA-seq), you know the struggle, transcriptomics alone doesn’t always give the full picture. Enter oligonucleotide-labeled antibodies, an elegant solution to detect proteins at the single-cell level. Importantly, as with any powerful technology, there’s a catch: optimizing large antibody panels is no small feat.
A recent study by Kleino et al. takes this challenge head-on, presenting a flexible and efficient antibody-oligo conjugation method to enhance protein detection in single-cell multi-omics experiments. Let’s dive into the key findings and why they matter.
More Oligos, More Problems? Finding the Sweet Spot
The team developed an adjustable method for conjugating oligonucleotides to antibodies using strain-promoted azide-alkyne cycloaddition (SPAAC), a copper-free click chemistry technique. The key takeaway? There’s a Goldilocks zone for oligo labeling.
- Labeling antibodies with 1 to 6 oligos per antibody was tested.
- Moderate labeling resulted in the best signal-to-noise ratio.
- Over-labeling weakened antibody performance, leading to unwanted background signals and reduced specificity.
So, if you’ve been wondering whether cramming more oligos onto an antibody is always better—the answer is a resounding no!
Optimizing Individual Clones: One Size Doesn’t Fit All
Not all antibodies behave the same when modified. The study found that different antibody clones responded differently to activation and oligo conjugation, making optimization essential for each clone.
- High activation levels reduced binding efficiency for some antibodies.
- Low to moderate activation preserved antigen recognition while improving signal strength.
- Testing each clone individually ensured the best performance for each antibody in the panel.
This means that when preparing antibody-oligo conjugates, it’s not enough to apply a one-size-fits-all approach. Instead, researchers should fine-tune activation and labeling conditions for each antibody to maximize specificity and minimize background noise.
CITE-seq: Boosting Weak Signals
For scientists using Cellular Indexing of Transcriptomes and Epitopes by Sequencing (CITE-seq), one of the biggest challenges is detecting low-expression proteins. The study found that fine-tuning the level of oligo labeling can help bring weak signals into the detectable range.
This optimization translates to:
- Improved detection of low-expressing proteins
- More balanced amplification of antibody signals
- Lower sequencing costs (because now, you’re not wasting reads on over-represented targets).
What This Means for Your Lab
Whether you're a multi-omics expert or just dipping your toes into the world of antibody-oligo conjugates, this research offers valuable insights for optimizing your workflow. By finding the right balance of oligo labeling, you can push the boundaries of single-cell analysis while keeping your experiments cost-effective and reproducible.
So, next time you're designing your CITE-seq panel remember, moderation is key, and not all antibody oligo conjugates are created equal.
Reference